Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
BPC-157+TB-500 Blend Buy 1 Buy 2 Save 5% Buy 3 Save 10% Buy 4 Save 15% FOR LABORATORY USE ONLY This product is intended strictly for controlled research environments and must not be: Used in any human or clinical testing Administered to individuals under any circumstances Distributed for unauthorised investigational use Technical Specifications: Synonyms: BPC-157 + TB-500 Blend
The FDA advisory panel is expected to continue voting Friday on whether other specific peptides are safe to mix, produce, and sell in the U.S
At Formation, our concierge dietitian creates personalized nutrition plans that support the biological processes BPC-157 is activating in your body
It is like saying the correct driving speed is somewhere between 15 and 90 miles per hour
US$ 24.84
US$ 23.59
US$ 23.34
US$ 28.17
